Allergan

Allergan’s Botox Approved for Pediatric Limb Spasticity Amid Split-Up Rumors
Allergan’s Botox Approved for Pediatric Limb Spasticity Amid Split-Up Rumors
Endpoints
Allergan
FDA
Botox
pediatric
upper limb spasticity
Flag link:
Analyst call with Allergan execs stokes anticipation of a plan to split the company in ‘a month or two’
Analyst call with Allergan execs stokes anticipation of a plan to split the company in ‘a month or two’
Endpoints
Allergan
Flag link:
Allergan says 'sense of urgency' could prompt move within 60 days
Allergan says 'sense of urgency' could prompt move within 60 days
Biopharma Dive
Allergan
Flag link:
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Ironwood Pharmaceuticals
Allergan
Linzess
clinical trials
IBS-C
Flag link:
Mark Your Calendar For These June PDUFA Dates
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Flag link:
Allergan puts Vraylar on blockbuster track with new bipolar depression nod
Allergan puts Vraylar on blockbuster track with new bipolar depression nod
Fierce Pharma
Allergan
FDA
Vraylar
bipolar disorder
Flag link:
Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch
Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch
Fierce Pharma
Evolus
Allergan
Jeuveau
drug launches
aesthetics
physicians
Flag link:
Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop
Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop
Endpoints
Allergan
Brent Saunders
Flag link:
Breast implants tied to rare cancer to remain on US market
Breast implants tied to rare cancer to remain on US market
Yahoo/AP
FDA
breast implants
Allergan
Flag link:
Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics
Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics
Endpoints
Allergan
Pharma CEOs
Brent Saunders
Flag link:
‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp
‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp
Endpoints
Allergan
Brent Saunders
shareholders
Flag link:
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More
Xconomy
FDA
CRISPR
gene therapy
Achaogen
Allergan
Alnylam
Adverum Biotechnologies
Blackstone Life Sciences
Flag link:
Supreme Court sends Allergan packing over Restasis tribal licensing strategy
Supreme Court sends Allergan packing over Restasis tribal licensing strategy
Fierce Pharma
Allergan
Supreme Court
Restasis
Flag link:
Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan
Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan
Endpoints
Allergan
Brent Saunders
activists
Flag link:
Allergan’s failed depression drug shows promise in opioid withdrawal
Allergan’s failed depression drug shows promise in opioid withdrawal
Fierce Biotech
Allergan
rapastinel
Naurex
opioids
opioid withdrawal
Flag link:
Allergan eye drug fails to impress on safety, upping pressure ahead of key meeting
Allergan eye drug fails to impress on safety, upping pressure ahead of key meeting
Biopharma Dive
Allergan
abicipar
wet age-related macular degeneration
Flag link:
Does an improved safety profile strengthen Allergan's case for a wet AMD challenge to Lucentis?
Does an improved safety profile strengthen Allergan's case for a wet AMD challenge to Lucentis?
Endpoints
Allergan
abicipar
wet age-related macular degeneration
Lucentis
Molecular Partners
Flag link:
Allergan taps Celgene vet Hugin for M&A guidance, but proxy brawlers aren't impressed
Allergan taps Celgene vet Hugin for M&A guidance, but proxy brawlers aren't impressed
Fierce Pharma
Allergan
investors
M&A
Bob Hugin
Flag link:
Allergan's NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA
Allergan's NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA
BioSpace
Allergan
migraines
ubrogepant
FDA
Flag link:
Allergan Rises After FDA Accepts License Applications for Botox Supplements
Allergan Rises After FDA Accepts License Applications for Botox Supplements
TheStreet.com
Allergan
Botox
FDA
pediatrics
limb spascity
Flag link:

Pages